Global, cGMP Micronizing and Milling for the Pharmaceutical Industry
- Company Details
- Products & Services
- White Papers
- Press Releases
- Regional Offices
- Contact Company
Catalent Acquires Accucaps to Expand Softigel Development and Manufacturing
Global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products Catalent has announced that the company has agreed to acquire...
Catalent Biologics Signs a Licence Agreement with Triphase Accelerator Corporation to Advance Smartag ADC to Clinic
Catalent has announced that Triphase Accelerator Corporation will obtain worldwide rights to further develop its proprietary CD22-4AP Antibody-Drug Conjugate (ADC), which has been developed...
Singapore Clinical Supply Facility to Receive $4.6m Investment from Catalent for Expansion
Catalent has announced it will build a new, flexible GMP space at its Singapore facility with an investment of...
Catalent Invests $4.6m to Further Expand Asia–Pacific Clinical Trials Hub in Singapore
Catalent Pharma Solutions has announced that it will invest $4.6m to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling...
Catalent Biologics and Cerenis Therapeutics Announce Phase III Trial of CER-001 in Europe and North America
Catalent Pharma Solutions has announced that Cerenis Therapeutics has advanced its leading clinical candidate, CER-001, into Phase III clinical studies across Europe and North America....